The prevention of migraine: a critical review with special emphasis on beta-adrenoceptor blockers
about
Norepinephrine and stimulant addictionThe selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptorsItalian guidelines for primary headaches: 2012 revised versionEvolution of β-blockers: from anti-anginal drugs to ligand-directed signalling.Expression of prostaglandin I2 (prostacyclin) receptor in blood of migraine patients: A potential biomarkerEvidence-based medicine in migraine prevention.Association between polymorphisms in the beta2-adrenoceptor gene and migraine in womenThe pharmacological management of migraine, part 2: preventative therapy.Prophylactic Treatment of Migraine.The pathophysiological and pharmacological basis of current drug treatment of migraine headache.Drug safety and tolerability in prophylactic migraine treatment.Role of botulinum toxin type A in the prophylactic treatment of migraine headaches.The effects of acute and preventive migraine therapies in a mouse model of chronic migraine.Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses.Migraine prophylactic medication usage patterns in The Netherlands.The effect of propranolol on glyceryltrinitrate-induced headache and arterial response.Effects of beta-adrenergic receptor blockers on cardiac function: a comparative study in male versus female rats.Synthesis and In Vitro Pharmacological Evaluation of 5-(Alkoxymethyl)-2-(3-alkylamino-2-hydroxypropoxy)phenylethanones Related to Acebutolol and Celiprolol.Magnesium in Migraine Prophylaxis-Is There an Evidence-Based Rationale? A Systematic Review.Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action.
P2860
Q24656833-2B8A26DA-1FB9-4E12-A9DA-2AA4DBF1B5DEQ24670735-F2A2A910-DE83-4DCF-BBCE-FEA145CCA314Q30466790-62AA525C-55C5-472D-9A51-737D125ED974Q34837191-BDAEDE0B-5AD8-4C7A-8749-A8C4FF1295B3Q35884499-40CA7B76-9EFF-47AD-8353-333481EBC56FQ36153368-A62FC06A-2C59-4349-97CE-9948BEF5DBF8Q37102319-C4BC063A-7A88-47EC-B2AD-CF6326E6B56BQ37313626-B58D9D1C-AD6F-408E-95D4-1546539444EFQ37703845-4C7B9F14-65CD-45F6-93DC-65B070894C1BQ38105147-0F77E3D4-D078-431B-8CB8-97A87E863F60Q38353242-DB057652-47E6-4B59-9F8F-664278E43CF8Q39359674-5499AEC7-BCF9-438B-88A7-06E10FE89960Q41417230-3F098E81-A535-4547-A7DF-7BBEC26FA2CFQ42191909-FAC02959-C2F8-4C88-ABB3-494BA934120FQ43415925-2EF3B497-89F5-4108-A1B8-09FB4DD4760AQ45164401-0A6EF4E6-85B9-4416-9CF2-673B7DCA5C10Q46049539-624FA268-772B-40E1-BFCC-AD3E9BB0EC84Q46204297-22499EEE-ACC0-4924-B4CC-E65F47D1F043Q48557043-51EDEC0C-79CD-4D93-91CD-EA19D4B0FC48Q53407201-A5819CD8-4406-4E93-BA6F-F2B881739934
P2860
The prevention of migraine: a critical review with special emphasis on beta-adrenoceptor blockers
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The prevention of migraine: a ...... on beta-adrenoceptor blockers
@ast
The prevention of migraine: a ...... on beta-adrenoceptor blockers
@en
The prevention of migraine: a ...... on beta-adrenoceptor blockers
@nl
type
label
The prevention of migraine: a ...... on beta-adrenoceptor blockers
@ast
The prevention of migraine: a ...... on beta-adrenoceptor blockers
@en
The prevention of migraine: a ...... on beta-adrenoceptor blockers
@nl
prefLabel
The prevention of migraine: a ...... on beta-adrenoceptor blockers
@ast
The prevention of migraine: a ...... on beta-adrenoceptor blockers
@en
The prevention of migraine: a ...... on beta-adrenoceptor blockers
@nl
P2860
P1476
The prevention of migraine: a ...... on beta-adrenoceptor blockers
@en
P2093
M C Michel
V Limmroth
P2860
P304
P356
10.1046/J.0306-5251.2001.01459.X
P407
P577
2001-09-01T00:00:00Z